UBS Group’s Agile Therapeutics AGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,387
Closed -$2.71K 10457
2023
Q4
$2.71K Buy
+1,387
New +$2.79K ﹤0.01% 8064
2023
Q3
Sell
-24
Closed -$71 10375
2023
Q2
$71 Buy
+24
New +$128 ﹤0.01% 8561
2023
Q1
Hold
0
9521
2022
Q4
Sell
-1,103
Closed -$12.8K 10671
2022
Q3
$16K Buy
1,103
+593
+116% +$14.6K ﹤0.01% 7753
2022
Q2
$30K Buy
510
+482
+1,721% +$69.9K ﹤0.01% 6410
2022
Q1
$12K Buy
28
+26
+1,300% +$16.6K ﹤0.01% 8245
2021
Q4
$2K Buy
+2
New +$2.82K ﹤0.01% 9892
2021
Q3
Hold
0
10403
2021
Q2
Sell
-7
Closed -$23.1K 9250
2021
Q1
$28K Hold
7
﹤0.01% 7075
2020
Q4
$42K Buy
+7
New +$41.2K ﹤0.01% 6346
2020
Q3
Sell
-11
Closed -$63K 7593
2020
Q2
$61K Buy
+11
New +$57.2K ﹤0.01% 5707
2020
Q1
Sell
-2
Closed -$12K 8576
2019
Q4
$12K Buy
+2
New +$6.99K ﹤0.01% 7204
2019
Q3
Sell
-3
Closed -$9K 8373
2019
Q2
$9K Hold
3
﹤0.01% 7153
2019
Q1
$9K Sell
3
-3
-50% -$6.36K ﹤0.01% 6902
2018
Q4
$7K Buy
+6
New +$9.19K ﹤0.01% 7440
2018
Q3
Sell
-2
Closed -$1K 8376
2018
Q2
$1K Hold
2
﹤0.01% 7863
2018
Q1
$10K Buy
+2
New +$13.2K ﹤0.01% 6893
2017
Q4
Sell
-1
Closed -$4K 8188
2017
Q3
$4K Hold
1
﹤0.01% 7337
2017
Q2
$8K Buy
+1
New +$6.92K ﹤0.01% 6938
2017
Q1
Sell
-2
Closed -$10.1K 7492
2016
Q4
$17K Buy
+2
New +$28K ﹤0.01% 6623
2016
Q3
Hold
0
7146
2016
Q2
Hold
0
7358
2016
Q1
Sell
-2
Closed -$25.8K 6950
2015
Q4
$39K Buy
2
+1
+100% +$15.8K ﹤0.01% 6067
2015
Q3
$19K Hold
1
﹤0.01% 6760
2015
Q2
$19K Hold
1
﹤0.01% 6929
2015
Q1
$16K Buy
+1
New +$17.5K ﹤0.01% 7233
2014
Q4
Hold
0
9296

Other funds holding AGRX